683 Capital Management, LLC
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 1404574
NEW YORK, NY
Position in HRMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,704,540
+$10,704,540 QoQ
Shares Held
294,000
Ownership
0.505%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#34
of 328 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Derivatives in HRMY
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$535,227
PutShares
14,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026683 Capital Management, LLC holds $349,034,024 across 34 Biotechnology names. HRMY ranks #12 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANAB |
Anaptysbio, Inc
|
660,000 | $44,550,000 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
290,000 | $35,548,200 | |
| 3 | MGTX |
MeiraGTx Holdings plc
|
2,300,000 | $31,073,000 | |
| 4 | WVE |
Wave Life Sciences, Inc.
|
4,950,000 | $28,759,500 | |
| 5 | QURE |
uniQure N.V.
|
575,000 | $26,484,500 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
389,081 | $21,376,110 | |
| 7 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,850,000 | $20,072,500 | |
| 8 | TRAX |
First Tracks Biotherapeutics, Inc.
|
750,000 | $15,090,000 |
All Filings in HRMY
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,704,540 | 294,000 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $535,227 | 14,700 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $411,747 | 14,700 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $15,529,300 | 415,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,771,920 | 282,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $9,543,200 | 302,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,957,000 | 300,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $10,323,000 | 300,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $12,000,000 | 300,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,900,150 | 295,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,906,100 | 295,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,497,500 | 325,000 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $1,615,000 | 50,000 | Call | Defined | 2024-02-14 | |
| 2023-09-30 | $11,469,500 | 350,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,557,000 | 300,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,897,500 | 150,000 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||